Revenue
2.57 million USD
2025-06-30 · USD
Fundies. English
Escalon Medical Corp.
EDGARAnnual consolidated revenue for 2026: about USD 12.74M, using the latest reported figures. The previous period, 2025, was about USD 12.05M.
Latest quarter
Operating margin
-14.47%
2025 Q4 · %
Operating cash flow
15.8 thousand USD
2025-06-30 · USD
Free cash flow
11.9 thousand USD
2025-06-30 · USD
- Cash and cash equivalents
- 3.07 million USD Source
Exact value
3065468 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 7.42 million shares Source
Exact value
7415329 shares
Reported share-count change
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Net income
4.01 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
Operating cash flow
-403 thousand USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: 85008 USD · 2025-07-01 – 2025-09-30 Source
- Operating cash flow: -432407 USD · 2025-07-01 – 2025-12-31 Source
- Operating cash flow: 85008 USD · 2025-07-01 – 2025-09-30 Source
- Operating cash flow: -151424 USD · 2025-07-01 – 2026-03-31 Source
- Operating cash flow: -432407 USD · 2025-07-01 – 2025-12-31 Source
- Operating cash flow: -402604 USD · 2025-07-01 – 2026-06-30 Source
- Operating cash flow: -151424 USD · 2025-07-01 – 2026-03-31 Source
Capital expenditure
4.42 thousand USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Capital expenditure: 4421 USD · 2025-07-01 – 2025-09-30 Source
- Capital expenditure: 4421 USD · 2025-07-01 – 2025-12-31 Source
- Capital expenditure: 4421 USD · 2025-07-01 – 2025-09-30 Source
- Capital expenditure: 4421 USD · 2025-07-01 – 2026-03-31 Source
- Capital expenditure: 4421 USD · 2025-07-01 – 2025-12-31 Source
- Capital expenditure: 4421 USD · 2025-07-01 – 2026-06-30 Source
- Capital expenditure: 4421 USD · 2025-07-01 – 2026-03-31 Source
Free cash flow
-407 thousand USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: 85008 USD · 2025-07-01 – 2025-09-30 Source
- Operating cash flow: -432407 USD · 2025-07-01 – 2025-12-31 Source
- Operating cash flow: 85008 USD · 2025-07-01 – 2025-09-30 Source
- Operating cash flow: -151424 USD · 2025-07-01 – 2026-03-31 Source
- Operating cash flow: -432407 USD · 2025-07-01 – 2025-12-31 Source
- Operating cash flow: -402604 USD · 2025-07-01 – 2026-06-30 Source
- Operating cash flow: -151424 USD · 2025-07-01 – 2026-03-31 Source
- Capital expenditure: 4421 USD · 2025-07-01 – 2025-09-30 Source
- Capital expenditure: 4421 USD · 2025-07-01 – 2025-12-31 Source
- Capital expenditure: 4421 USD · 2025-07-01 – 2025-09-30 Source
- Capital expenditure: 4421 USD · 2025-07-01 – 2026-03-31 Source
- Capital expenditure: 4421 USD · 2025-07-01 – 2025-12-31 Source
- Capital expenditure: 4421 USD · 2025-07-01 – 2026-06-30 Source
- Capital expenditure: 4421 USD · 2025-07-01 – 2026-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-13.
Financial data available through: 2026-06-30.
Coverage by financial measure
- Revenue: 7 of 11 periods available· newest 2026-06-30
- Operating income: 11 of 11 periods available· newest 2026-06-30
- Net income: 11 of 11 periods available· newest 2026-06-30
- Operating cash flow: 11 of 11 periods available· newest 2026-06-30
- Capital expenditure: 5 of 11 periods available· newest 2026-06-30
- Total assets: 7 of 11 periods available· newest 2026-06-30
- Total liabilities: 7 of 11 periods available· newest 2026-06-30
- Current assets: 7 of 11 periods available· newest 2026-06-30
- Current liabilities: 7 of 11 periods available· newest 2026-06-30
- Cash and cash equivalents: 7 of 11 periods available· newest 2026-06-30
- long term debt: No compatible figures in this window
- Shares outstanding: 7 of 11 periods available· newest 2026-06-30
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+5.7%Prior period
USD 12.05 million
–
Current period
USD 12.74 million
–
Exact inputs and evidence
12736145 − 12046148 = 689997 USD
12046148 USD · 2024-07-01 – 2025-06-30
Inspect prior input Prior source12736145 USD · 2025-07-01 – 2026-06-30
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+3,702.5%Prior period
USD 105,525
–
Current period
USD 4.01 million
–
Exact inputs and evidence
4012626 − 105525 = 3907101 USD
105525 USD · 2024-07-01 – 2025-06-30
Inspect prior input Prior source4012626 USD · 2025-07-01 – 2026-06-30
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-205.7%Prior period
USD 380,725
–
Current period
−USD 402,604
–
Exact inputs and evidence
-402604 − 380725 = -783329 USD
380725 USD · 2024-07-01 – 2025-06-30
Inspect prior input Prior source-402604 USD · 2025-07-01 – 2026-06-30
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+13.9%Prior period
USD 3,880
–
Current period
USD 4,421
–
Exact inputs and evidence
4421 − 3880 = 541 USD
3880 USD · 2024-07-01 – 2025-06-30
Inspect prior input Prior source4421 USD · 2025-07-01 – 2026-06-30
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2026 2025-07-01 – 2026-06-30
- Revenue USD 12.74 million 100% of revenue
- Operating costs Derived USD 12.69 million 100% of revenue
- Operating income USD 45,235 0.4% of revenue
- Tax, interest and other Derived −USD 3.97 million −31% of revenue
- Net income USD 4.01 million 32% of revenue
Cash
- Operating cash flow −USD 402,604 −3.2% of revenue
- Capital expenditure USD 4,421 0% of revenue
- Free cash flow Derived −USD 407,025 −3.2% of revenue
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2017 Operating loss: operating costs were 106% of revenue.
- 2018 Net income was higher than operating income, so the split is not drawn.
- 2019 Operating loss: operating costs were 103% of revenue.
- 2020 Operating loss: operating costs were 115% of revenue.
- 2025 99%
- 2026 Net income was higher than operating income, so the split is not drawn.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2017 2016-07-01 – 2017-06-30 | 11234868 | 11861761 Derived | -626893 | 100002 Derived | -726895 | Unavailable | Source
|
| 2018 2017-07-01 – 2018-06-30 | 11402272 | 11197552 Derived | 204720 | -378955 Derived | 583675 | Unavailable | Source
|
| 2019 2018-07-01 – 2019-06-30 | 9626663 | 9879618 Derived | -252955 | -2939 Derived | -250016 | Unavailable | Source
|
| 2020 2019-07-01 – 2020-06-30 | 9400031 | 10799694 Derived | -1399663 | -749383 Derived | -650280 | Unavailable | Source
|
| 2025 2024-07-01 – 2025-06-30 | 12046148 | 11912931 Derived | 133217 | 27692 Derived | 105525 | 376845 Derived | Source
|
| 2026 2025-07-01 – 2026-06-30 | 12736145 | 12690910 Derived | 45235 | -3967391 Derived | 4012626 | -407025 Derived | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 12.7M 2026
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Revenue | 11576466 |
|
| 2017 | Revenue | 11234868 |
|
| 2018 | Revenue | 11402272 |
|
| 2019 | Revenue | 9626663 |
|
| 2020 | Revenue | 9400031 |
|
| 2025 | Revenue | 12046148 |
|
| 2026 | Revenue | 12736145 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
5.7% 2026
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Year over year | No prior comparable period |
|
| 2017 | Year over year | -3% |
|
| 2018 | Year over year | 1.5% |
|
| 2019 | Year over year | -15.6% |
|
| 2020 | Year over year | -2.4% |
|
| 2025 | Year over year | No prior comparable period |
|
| 2026 | Year over year | 5.7% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin 0.4% 2026
Net margin 31.5% 2026
Free cash flow margin -3.2% 2026
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Operating margin | -9.9% |
|
| 2017 | Operating margin | -5.6% |
|
| 2018 | Operating margin | 1.8% |
|
| 2019 | Operating margin | -2.6% |
|
| 2020 | Operating margin | -14.9% |
|
| 2025 | Operating margin | 1.1% |
|
| 2026 | Operating margin | 0.4% |
|
| 2016 | Net margin | -9.9% |
|
| 2017 | Net margin | -6.5% |
|
| 2018 | Net margin | 5.1% |
|
| 2019 | Net margin | -2.6% |
|
| 2020 | Net margin | -6.9% |
|
| 2025 | Net margin | 0.9% |
|
| 2026 | Net margin | 31.5% |
|
| 2016 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | Not reported |
|
| 2018 | Free cash flow margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | 3.1% |
|
| 2026 | Free cash flow margin | -3.2% |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -402.6K 2026
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Operating cash flow | Not reported | No source recorded |
| 2017 | Operating cash flow | -505996 |
|
| 2018 | Operating cash flow | 106736 |
|
| 2019 | Operating cash flow | -472689 |
|
| 2020 | Operating cash flow | -168495 |
|
| 2025 | Operating cash flow | 380725 |
|
| 2026 | Operating cash flow | -402604 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD -407K 2026
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Free cash flow | Unavailable | No source recorded |
| 2017 | Free cash flow | Unavailable |
|
| 2018 | Free cash flow | Unavailable |
|
| 2019 | Free cash flow | Unavailable |
|
| 2020 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | 376845 |
|
| 2026 | Free cash flow | -407025 |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
35.1% 2026
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Liabilities / assets | 65.5% |
|
| 2017 | Liabilities / assets | 76.3% |
|
| 2018 | Liabilities / assets | 55.5% |
|
| 2019 | Liabilities / assets | 57.8% |
|
| 2020 | Liabilities / assets | 73.6% |
|
| 2025 | Liabilities / assets | 61.6% |
|
| 2026 | Liabilities / assets | 35.1% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
2.94× 2026
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Current assets / current liabilities | 1.63× |
|
| 2017 | Current assets / current liabilities | 1.38× |
|
| 2018 | Current assets / current liabilities | 2.04× |
|
| 2019 | Current assets / current liabilities | 1.89× |
|
| 2020 | Current assets / current liabilities | 1.51× |
|
| 2025 | Current assets / current liabilities | 1.72× |
|
| 2026 | Current assets / current liabilities | 2.94× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2017 2016-07-01 – 2017-06-30 | −USD 726,895 Exact valueExact value: -726895 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 505,996 Exact valueExact value: -505996 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2017-07-01 – 2018-06-30 | USD 583,675 Exact valueExact value: 583675 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 106,736 Exact valueExact value: 106736 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2018-07-01 – 2019-06-30 | −USD 250,016 Exact valueExact value: -250016 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 472,689 Exact valueExact value: -472689 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2019-07-01 – 2020-06-30 | −USD 650,280 Exact valueExact value: -650280 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 168,495 Exact valueExact value: -168495 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2020-07-01 – 2021-06-30 | −USD 52,023 Exact valueExact value: -52023 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 838,705 Exact valueExact value: 838705 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2021-07-01 – 2022-06-30 | USD 18,081 Exact valueExact value: 18081 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.05 million Exact valueExact value: -1049925 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.05 million Calculation and evidence-1049925 − 0 USD Exact free cash flow: -1049925 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2022-07-01 – 2023-06-30 | USD 456,826 Exact valueExact value: 456826 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 325,146 Exact valueExact value: 325146 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 6,687 Exact valueExact value: 6687 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 318,459 Calculation and evidence325146 − 6687 USD Exact free cash flow: 318459 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2023-07-01 – 2024-06-30 | −USD 125,261 Exact valueExact value: -125261 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 602,771 Exact valueExact value: -602771 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 40,285 Exact valueExact value: 40285 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 643,056 Calculation and evidence-602771 − 40285 USD Exact free cash flow: -643056 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2024-07-01 – 2025-06-30 | USD 105,525 Exact valueExact value: 105525 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 380,725 Exact valueExact value: 380725 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3,880 Exact valueExact value: 3880 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 376,845 Calculation and evidence380725 − 3880 USD Exact free cash flow: 376845 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2026 2025-07-01 – 2026-06-30 | USD 4.01 million Exact valueExact value: 4012626 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 402,604 Exact valueExact value: -402604 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 4,421 Exact valueExact value: 4421 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 407,025 Calculation and evidence-402604 − 4421 USD Exact free cash flow: -407025 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
154 filings · 4,869 latest values · 4,869 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0000862668, 862668, ESMC, edgar:862668
Also known as ESCALON MEDICAL CORP, ESCALON MEDICAL CORP., Escalon Medical Corp.